Windsor Hospital Corporation
Windsor Hospital Corporation was paid $55K by Medicaid between Jan 2018 and Jan 2024, across 13 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 34% of everything it billed.
WINDSOR, VT 05089
Next to other Critical Access Hospital providers in Vermont
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,256 | $4K | |
| 2019 | 1,550 | $7K | |
| 2020 | 1,389 | $13K | |
| 2021 | 1,640 | $24K | |
| 2022 | 821 | $5K | |
| 2023 | 97 | $2K | |
| 2024incomplete | 26 | $635.79 |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 34% | 268 | 224 | $19K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 100 | 63 | $9K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 1,136 | 322 | $9K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.1% | 986 | 258 | $4K |
| 80053 | Comprehensive metabolic panel | 7.7% | 1,133 | 725 | $4K |
| 36415 | Collection of venous blood by venipuncture | 5.9% | 2,018 | 1,295 | $3K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.0% | 343 | 280 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.5% | 84 | 79 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.3% | 587 | 392 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 28 | 24 | $242.79 |
| G0008 | Administration of influenza virus vaccine | <1% | 41 | 25 | $4.39 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 12 | 12 | $0.00 |
1 more codes
| 99284 | Emergency room visit (serious) | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Windsor Hospital Corporation | Windsor, VT | $519K |
| Windsor Hospital Corporation | Windsor, VT | $45K |
| Windsor Hospital Corporation | Windsor, VT | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.